BETA DRUGS LIMITED (BETA) financials — quarterly results, P&L, cash flow, balance sheet, shareholding
Beta Drugs Ltd is engaged in manufacturing of a wide range of oncology (anti-cancer) drugs in India. It has operations in the domestic and export markets.[1]
Beta Drugs Limited
BETA
Market Cap₹2,398Cr.
Current Price₹2,301
High / Low₹2,674/990
Stock P/E150
Book Value₹148
Dividend Yield0.00%
ROCE11.2%
ROE10.3%
Face Value₹10.0
Beta Drugs Ltd is engaged in manufacturing of a wide range of oncology (anti-cancer) drugs in India. It has operations in the domestic and export markets.[1]
Quarterly Results
Yearly Results
Shareholding Pattern
Shareholding Trend
Balance Sheet
Cash Flows
Last updated at: 24 July 2026 at 14:43:13